Frank manages ECG’s healthcare practice, which have achieved impressive success at FDA Advisory Committee meetings, EMA Oral Explanations, and myriad other critical health authority interactions throughout the development timeline for drugs, devices, biologics, and vaccines.
Frank and ECG have an incomparable record of success in building the argumentation and advocacy necessary for helping others see the benefits of products across a wide variety of therapeutics areas, while maintaining appropriate context around risk.
David Day Senior Consultant Bio
F. Raymond Carillo Assistant Director Bio Coming Soon
Other ECG team members you may work with.